Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug development
Pharma
Amid ongoing launches, Novo eyes rare disease leadership
As Novo advances its rare disease ambitions, the success of a hemophilia launch and late-stage sickle cell disease trial will be key.
Fraiser Kansteiner
Mar 7, 2025 9:20am
Atara hit with cell therapy clinical hold after FDA inspection
Jan 21, 2025 9:59am
Fierce 50 of 2024
Sep 9, 2024 5:02am
Merck, AstraZeneca, Gilead: The race for supremacy in an ADC field
Aug 2, 2024 4:00pm
Shionogi's antiviral comes up short in global COVID-19 trial
May 13, 2024 10:48am
Medincell, AbbVie set out to create new long-acting injectables
Apr 17, 2024 2:49pm
